Search

Brian E. Mcdowell

Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
4161, 1624
Total Applications
1622
Issued Applications
1025
Pending Applications
135
Abandoned Applications
522

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5272259 [patent_doc_number] => 20090076035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED PALIPERIDONE' [patent_app_type] => utility [patent_app_number] => 12/208653 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3386 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076035.pdf [firstpage_image] =>[orig_patent_app_number] => 12208653 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/208653
DEUTERIUM-ENRICHED PALIPERIDONE Sep 10, 2008 Abandoned
Array ( [id] => 4566179 [patent_doc_number] => 07846938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety' [patent_app_type] => utility [patent_app_number] => 12/207833 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 40669 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846938.pdf [firstpage_image] =>[orig_patent_app_number] => 12207833 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/207833
Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety Sep 9, 2008 Issued
Array ( [id] => 5272268 [patent_doc_number] => 20090076044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY' [patent_app_type] => utility [patent_app_number] => 12/207994 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29329 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076044.pdf [firstpage_image] =>[orig_patent_app_number] => 12207994 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/207994
VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY Sep 9, 2008 Abandoned
Array ( [id] => 6536925 [patent_doc_number] => 20100204215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/677030 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11497 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204215.pdf [firstpage_image] =>[orig_patent_app_number] => 12677030 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677030
Diaminophenothiazine compounds, a method for preparing same and uses thereof Sep 4, 2008 Issued
Array ( [id] => 8103979 [patent_doc_number] => 08153635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Compounds and compositions as modulators of GPR119 activity' [patent_app_type] => utility [patent_app_number] => 12/204600 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70040 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153635.pdf [firstpage_image] =>[orig_patent_app_number] => 12204600 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/204600
Compounds and compositions as modulators of GPR119 activity Sep 3, 2008 Issued
Array ( [id] => 5324267 [patent_doc_number] => 20090062257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED VARENICLINE' [patent_app_type] => utility [patent_app_number] => 12/198054 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3129 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062257.pdf [firstpage_image] =>[orig_patent_app_number] => 12198054 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/198054
DEUTERIUM-ENRICHED VARENICLINE Aug 24, 2008 Abandoned
Array ( [id] => 5279533 [patent_doc_number] => 20090131665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI' [patent_app_type] => utility [patent_app_number] => 12/229701 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6766 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131665.pdf [firstpage_image] =>[orig_patent_app_number] => 12229701 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/229701
Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI Aug 24, 2008 Abandoned
Array ( [id] => 5272266 [patent_doc_number] => 20090076042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED ERLOTINIB' [patent_app_type] => utility [patent_app_number] => 12/196369 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3639 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076042.pdf [firstpage_image] =>[orig_patent_app_number] => 12196369 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/196369
DEUTERIUM-ENRICHED ERLOTINIB Aug 21, 2008 Abandoned
Array ( [id] => 5324367 [patent_doc_number] => 20090062357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED FLUCONAZOLE' [patent_app_type] => utility [patent_app_number] => 12/195956 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3638 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062357.pdf [firstpage_image] =>[orig_patent_app_number] => 12195956 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/195956
DEUTERIUM-ENRICHED FLUCONAZOLE Aug 20, 2008 Abandoned
Array ( [id] => 5272267 [patent_doc_number] => 20090076043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED ALFUZOSIN' [patent_app_type] => utility [patent_app_number] => 12/196198 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3664 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076043.pdf [firstpage_image] =>[orig_patent_app_number] => 12196198 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/196198
DEUTERIUM-ENRICHED ALFUZOSIN Aug 20, 2008 Abandoned
Array ( [id] => 5324378 [patent_doc_number] => 20090062368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED SUNITINIB' [patent_app_type] => utility [patent_app_number] => 12/195881 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4531 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062368.pdf [firstpage_image] =>[orig_patent_app_number] => 12195881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/195881
DEUTERIUM-ENRICHED SUNITINIB Aug 20, 2008 Abandoned
Array ( [id] => 5324333 [patent_doc_number] => 20090062323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED IRINOTECAN' [patent_app_type] => utility [patent_app_number] => 12/195936 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3524 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062323.pdf [firstpage_image] =>[orig_patent_app_number] => 12195936 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/195936
DEUTERIUM-ENRICHED IRINOTECAN Aug 20, 2008 Abandoned
Array ( [id] => 5272255 [patent_doc_number] => 20090076031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED BORTEZOMIB' [patent_app_type] => utility [patent_app_number] => 12/196216 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3364 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076031.pdf [firstpage_image] =>[orig_patent_app_number] => 12196216 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/196216
DEUTERIUM-ENRICHED BORTEZOMIB Aug 20, 2008 Abandoned
Array ( [id] => 5324313 [patent_doc_number] => 20090062303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED ZIPRASIDONE' [patent_app_type] => utility [patent_app_number] => 12/195826 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5142 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062303.pdf [firstpage_image] =>[orig_patent_app_number] => 12195826 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/195826
DEUTERIUM-ENRICHED ZIPRASIDONE Aug 20, 2008 Abandoned
Array ( [id] => 5324377 [patent_doc_number] => 20090062367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'DEUTERIUM-ENRICHED ELETRIPTAN' [patent_app_type] => utility [patent_app_number] => 12/195581 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4773 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062367.pdf [firstpage_image] =>[orig_patent_app_number] => 12195581 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/195581
DEUTERIUM-ENRICHED ELETRIPTAN Aug 20, 2008 Abandoned
Array ( [id] => 5410703 [patent_doc_number] => 20090124602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/187909 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81107 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124602.pdf [firstpage_image] =>[orig_patent_app_number] => 12187909 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/187909
Amino substituted pyridines as potent kinase inhibitors Aug 6, 2008 Issued
Array ( [id] => 9455466 [patent_doc_number] => 08716476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Process for the preparation of alfuzosin hydrochloride' [patent_app_type] => utility [patent_app_number] => 12/671418 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5890 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671418 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/671418
Process for the preparation of alfuzosin hydrochloride Jul 31, 2008 Issued
Array ( [id] => 6320931 [patent_doc_number] => 20100196460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Integrated Photoactive Agents for Real-Time Monitoring of Hemostasis' [patent_app_type] => utility [patent_app_number] => 12/669497 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7186 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196460.pdf [firstpage_image] =>[orig_patent_app_number] => 12669497 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/669497
Integrated photoactive agents for real-time monitoring of hemostasis Jul 30, 2008 Issued
Array ( [id] => 6466382 [patent_doc_number] => 20100190779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'VIRAL POLYMERASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/671780 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27730 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190779.pdf [firstpage_image] =>[orig_patent_app_number] => 12671780 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/671780
Viral polymerase inhibitors Jul 30, 2008 Issued
Array ( [id] => 7778549 [patent_doc_number] => 20120040997 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-16 [patent_title] => 'VINYL-ARYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES' [patent_app_type] => utility [patent_app_number] => 12/452980 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26693 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0040/20120040997.pdf [firstpage_image] =>[orig_patent_app_number] => 12452980 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/452980
Vinyl-aryl derivatives for inflammation and immune-related uses Jul 30, 2008 Issued
Menu